Real-time enrollment status for this solid tumors clinical trial
Current Status
Recruiting
Checked: July 16, 2026 at 11:05 PM UTC
| NCT Number | NCT06816992 |
| Recruiting Status | Recruiting |
| Condition | Solid Tumors |
| Phase | PHASE1 |
| Target Enrollment | 76 participants |
| Active Locations | 2 sites in the US |
| Sponsor | ORIC Pharmaceuticals |
| Last Updated on CT.gov | April 24, 2026 (Apr 24, 2026) |
As of July 16, 2026: Clinical trial NCT06816992 is currently recruiting participants. This phase1 study for solid tumors is actively seeking new participants at 2 locations across the United States. The study is sponsored by ORIC Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06816992 is actively recruiting participants as of July 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06816992 was last updated Apr 24, 2026 (April 24, 2026). HelloStudys verifies this status automatically.